Skip to content
← Back to this collection

PUBLICATIONS · 37992261

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Feb 10
First author
Hoster E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hoster E
      type
      Author
    2. name
      Delfau-Larue MH
      type
      Author
    3. name
      Macintyre E
      type
      Author
    4. name
      Jiang L
      type
      Author
    5. name
      Stilgenbauer S
      type
      Author
    6. name
      Vehling-Kaiser U
      type
      Author
    7. name
      Salles G
      type
      Author
    8. name
      Thieblemont C
      type
      Author
    9. name
      Tilly H
      type
      Author
    10. name
      Wirths S
      type
      Author
    11. name
      Feugier P
      type
      Author
    12. name
      Hübel K
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hoster E
      type
      Author
    2. name
      Delfau-Larue MH
      type
      Author
    3. name
      Macintyre E
      type
      Author
    4. name
      Jiang L
      type
      Author
    5. name
      Stilgenbauer S
      type
      Author
    6. name
      Vehling-Kaiser U
      type
      Author
    7. name
      Salles G
      type
      Author
    8. name
      Thieblemont C
      type
      Author
    9. name
      Tilly H
      type
      Author
    10. name
      Wirths S
      type
      Author
    11. name
      Feugier P
      type
      Author
    12. name
      Hübel K
      type
      Author
    bibliography ids
    1. nci-bib-8b9ab0f8db10941491c8344f
    book metadata
    content sha256
    5ee1bfba5cbe2fd72f6d71f1504eb41fc21ed84e3fa8525240af4965fb567b5d
    document type
    citation
    dois
    1. 10.1200/JCO.23.00899
    electronic publication date
    display
    2023 Nov 22
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37992261
    immutable id
    pubmed:37992261@5ee1bfba5cbe2fd72f6d71f1504eb41fc21ed84e3fa8525240af4965fb567b5d
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    5
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    538-549
    volume
    42
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37992261
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      56f4190abd40c531e18ee2e6161fa646fc582af84edf9c7577bfd27f7f242797
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Feb 10
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37992261/
      title
      Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.

      Preserved source evidence · Not medical advice